Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,920.00
+220.00 (2.86%)
At close: Dec 29, 2025
18.80%
Market Cap191.40B
Revenue (ttm)8.27B
Net Income (ttm)-1.28B
Shares Out24.17M
EPS (ttm)-53.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume54,740
Average Volume76,604
Open7,620.00
Previous Close7,700.00
Day's Range7,550.00 - 7,970.00
52-Week Range6,490.00 - 13,200.00
Beta0.36
RSI47.39
Earnings DateMar 17, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.